Sponsor Pipeline

SymBio Pharmaceuticals Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
1
Recruiting
1
Phase 3
5
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-12 NCT04706923
A Phase 2a Study of IV BCV in Subjects With Adenovirus Infection		 Trial completed
2026-08-12 NCT04706923
A Phase 2a Study of IV BCV in Subjects With Adenovirus Infection		 Trial arms changed: 4 -> 7
2026-08-12 NCT04706923
A Phase 2a Study of IV BCV in Subjects With Adenovirus Infection		 date change Primary completion moved earlier: 2026-09-30 -> 2025-05-15
2026-08-12 NCT04706923
A Phase 2a Study of IV BCV in Subjects With Adenovirus Infection		 date change Completion moved earlier: 2026-09-30 -> 2025-05-15
2026-07-23 NCT07387367
A Phase 3 Trial to Compare IV BCV Versus IV CDV for Treatment of Adenovirus Infection…		 Trial sites expanded: 61 -> 81 locations
Active Trials by Phase
Phase 3
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07387367 A Phase 3 Trial to Compare IV BCV Versus IV CDV for Treatment of Adenovirus Infection… Adenovirus Infections Recruiting
Get alerts when SymBio Pharmaceuticals's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free